{"?xml":{"@version":"1.0"},"edm:RDF":{"@xmlns:dc":"http://purl.org/dc/elements/1.1/","@xmlns:edm":"http://www.europeana.eu/schemas/edm/","@xmlns:wgs84_pos":"http://www.w3.org/2003/01/geo/wgs84_pos","@xmlns:foaf":"http://xmlns.com/foaf/0.1/","@xmlns:rdaGr2":"http://rdvocab.info/ElementsGr2","@xmlns:oai":"http://www.openarchives.org/OAI/2.0/","@xmlns:owl":"http://www.w3.org/2002/07/owl#","@xmlns:rdf":"http://www.w3.org/1999/02/22-rdf-syntax-ns#","@xmlns:ore":"http://www.openarchives.org/ore/terms/","@xmlns:skos":"http://www.w3.org/2004/02/skos/core#","@xmlns:dcterms":"http://purl.org/dc/terms/","edm:WebResource":[{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-8A9PZ1LX/6ade23a5-01e9-4461-938f-6f37e58b27d8/HTML","dcterms:extent":"47 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-8A9PZ1LX/b0a5a73d-ad7c-468c-bc0a-270f3d25d1c0/PDF","dcterms:extent":"124 KB"},{"@rdf:about":"http://www.dlib.si/stream/URN:NBN:SI:doc-8A9PZ1LX/3ab51bd5-1064-4b2d-ba4a-7e338f13cd52/TEXT","dcterms:extent":"24 KB"}],"edm:TimeSpan":{"@rdf:about":"1929-2026","edm:begin":{"@xml:lang":"en","#text":"1929"},"edm:end":{"@xml:lang":"en","#text":"2026"}},"edm:ProvidedCHO":{"@rdf:about":"URN:NBN:SI:doc-8A9PZ1LX","dcterms:isPartOf":[{"@rdf:resource":"https://www.dlib.si/details/urn:nbn:si:spr-a30mfzkp"},{"@xml:lang":"sl","#text":"Zdravniški vestnik"}],"dcterms:issued":"2008","dc:creator":["Lokar, Lidija","Perbil Lazič, Katja","Urlep-Šalinović, Veronika"],"dc:format":[{"@xml:lang":"sl","#text":"številka:1"},{"@xml:lang":"sl","#text":"6 strani"},{"@xml:lang":"sl","#text":"letnik:77"},{"@xml:lang":"sl","#text":"str. I-171-I-176"}],"dc:identifier":["ISSN:1318-0347","COBISSID:2917695","URN:URN:NBN:SI:doc-8A9PZ1LX"],"dc:language":"sl","dc:publisher":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"dc:subject":[{"@xml:lang":"en","#text":"Blood Component Transfusion"},{"@xml:lang":"sl","#text":"Eritrociti"},{"@xml:lang":"en","#text":"Erythrocytes"},{"@xml:lang":"sl","#text":"Kakovost, nadzor"},{"@xml:lang":"sl","#text":"Krvna komponenta, transfuzija"},{"@xml:lang":"sl","#text":"kvaliteta"},{"@xml:lang":"sl","#text":"nadzor"},{"@xml:lang":"en","#text":"Quality Control"},{"@xml:lang":"en","#text":"Safety"},{"@xml:lang":"en","#text":"security"},{"@xml:lang":"sl","#text":"transfuzija"},{"@xml:lang":"sl","#text":"transfuziologija"},{"@xml:lang":"sl","#text":"Varnost"}],"dcterms:temporal":{"@rdf:resource":"1929-2026"},"dc:title":{"@xml:lang":"sl","#text":"Nadzor kakovosti eritrocitnih pripravkov v obdobju 2005-2007| Quality control of red blood cell components in the period 2005-2007|"},"dc:description":[{"@xml:lang":"sl","#text":"Background. An imperative in transfusion medicine is to assure safe and quality blood and blood components for transfused patients. The quality assurance system in transfusion medicine that comprises quality control is very important for safe blood components supply. The quality control is necessary at all levels including blood collection, processing, testing, storage, transportation and transfusion to patients. Guide of the Council of Europe recommends the quality control should performed at minimum 1 % of all prepared blood components and determines definitive parameters of quality for each blood component. Material and methods. In three years (2005-2007), 56,691 units of whole blood were collected, among them 48,418 methods (85.4 %) units were processed into red cell concentrates in additive solution - RCC (SAGM) and 8273 (14.6 %) in to pre-storage leukodepleted red cell concentrates. Planned quality control was determined in 758 (1.6 %) units of blind selected RCC and in 381 (4.6 %) units of leukodepleted RCC. On the first day of preparation for each unit of RCC, volume, haemoglobin (HB) concentration and hematocrit (Hct) were measured and on the last day of the storage the concentration of free haemoglobin and sterility were determined. Among parameters determined in RCC, in units of leukodepleted RCC residual leukocytes were counted by flow cytometer. For all parameters the mean value and standard deviation were calculated. Results. In RCC the volume was suitable in 94 %, Hct in 83 %, HB in 99 %, hemolysis in 94 % and sterility in 100 %. In leukodepleted RCC the volume was suitable in 94 %, hematocrit in 97 %, hemoglobin in 99.3 %, hemolysis in 97.3 %, sterility in 100 % and residual leukocytes were below 1 x 10(6) in 97 % of tested units. Conclusions. Quality control of RCC and leukodepleted RCC shows that the measured parameters were in accordance with requirements of quality and that our patients were treated by red blood cells components of high quality"},{"@xml:lang":"sl","#text":"Izhodišča. V transfuzijski medicini je treba zagotavljati varne in kakovostne krvne komponente za bolnike, zdravljene s krvjo. Sistem zagotavljanja kakovosti v transfuzijski medicini, ki vključuje nadzor kakovosti, je zelo pomemben dejavnik pri uresničevanju te zahteve. Nadzor kakovosti je potrebno izvajati na vseh ravneh preskrbe s krvjo: od zbiranja krvi, predelave, testiranja, shranjevanja, prevoza in dajanja transfuzije krvi bolniku. Po priporočilih Sveta Evrope je potrebno pri vsaj 1 % pripravljenih krvnih komponent opraviti nadzor kakovosti in določiti predpisane kazalce kakovosti za določeno komponento. Material in metode. V treh letih (2005-2007) smo zbrali 56691 enot polne krvi in predelali v 48418 (85,4 %) enot koncentriranih eritrocitov v ohranitveni tekočini SAGM (KES) in v 8273 (14,6 %) enot filtriranih eritrocitnih koncentratov (KEF), ki smo jih filtrirali neposredno po odvzemu. Nadzor kakovosti smo izvedli po planu pri naključno zbranih 758 (1,6 %) enotah KES in pri 381(4,6 %) enotah KEF. Pri enotah KES smo določali 1. dne po pripravi volumen, hematokrit (Hct) in koncentracijo hemoglobina (HB), zadnjega dne uporabnosti pa se koncentracijo prostega hemoglobina in sterilnost. Enotam KEF smo določali poleg ze omenjenih parametrov pri KES se število preostalih levkocitov s pretočnim citometrom. Za vse kazalce smo izračunali aritmetično povprečno vrednost (X _ ) in standardno deviacijo. Rezultati. Predpisanim vrednostim za volumen je ustrezalo 94 % vseh testiranih enot KES, za Hct 83 %, za HB 99 %, za hemolizo na koncu shranjevanja 94 % in za sterilnost 100 %. Pri KEF je predpisanim vrednostim za volumen ustrezalo 94 % vseh testiranih enot, za Hct 97 %, za HB 99,3 %, za hemolizo na koncu shranjevanja 97,3 %, za sterilnost 100 %. Število preostalih levkocitov pa je bilo pri 97 % testiranih enot KEF < 1 x 10 na 6. Zaključki. Izsledki testiranja pri nadzoru kakovosti KES in KEF kažejo, da merjeni parametri ustrezajo zahtevam kakovosti in da našim bolnikom zagotavljamo visoko kakovostne eritrocitne krvne pripravke"}],"edm:type":"TEXT","dc:type":[{"@xml:lang":"sl","#text":"znanstveno časopisje"},{"@xml:lang":"en","#text":"journals"},{"@rdf:resource":"http://www.wikidata.org/entity/Q361785"}]},"ore:Aggregation":{"@rdf:about":"http://www.dlib.si/?URN=URN:NBN:SI:doc-8A9PZ1LX","edm:aggregatedCHO":{"@rdf:resource":"URN:NBN:SI:doc-8A9PZ1LX"},"edm:isShownBy":{"@rdf:resource":"http://www.dlib.si/stream/URN:NBN:SI:doc-8A9PZ1LX/b0a5a73d-ad7c-468c-bc0a-270f3d25d1c0/PDF"},"edm:rights":{"@rdf:resource":"http://creativecommons.org/licenses/by-nc/4.0/"},"edm:provider":"Slovenian National E-content Aggregator","edm:intermediateProvider":{"@xml:lang":"en","#text":"National and University Library of Slovenia"},"edm:dataProvider":{"@xml:lang":"sl","#text":"Slovensko zdravniško društvo"},"edm:object":{"@rdf:resource":"http://www.dlib.si/streamdb/URN:NBN:SI:doc-8A9PZ1LX/maxi/edm"},"edm:isShownAt":{"@rdf:resource":"http://www.dlib.si/details/URN:NBN:SI:doc-8A9PZ1LX"}}}}